Autism Diagnostic Observation Schedule (ados) - Pharma

Relevant Publications

Cord blood cytokine profiles in children later diagnosed with autism spectrum disorder: Results from the prospective MARBLES study.

Issue Release: 2024

Short-term and Long-term Stability of the Autism Diagnostic Observation Schedule (ADOS-2) Calibrated Comparison Scores (CCS) and Classification Scores in Youth with Down Syndrome or Fragile X Syndrome with Intellectual Disability.

Issue Release: 2024

Modification and Validation of an Autism Observational Assessment Including ADOS-2 for Use with Children with Visual Impairment.

Issue Release: 2024

Assessment of Psychotic Risk in a Sample of Children and Adolescents with Autism Spectrum Disorder Compared to a Group of \"Clinical High Risk\" Patients: A Preliminary Study.

Issue Release: 2024

Utility of the Language Use Inventory in Young Children at Elevated Likelihood of Autism.

Issue Release: 2024

Arachidonic acid-derived dihydroxy fatty acids in neonatal cord blood relate symptoms of autism spectrum disorders and social adaptive functioning: Hamamatsu Birth Cohort for Mothers and Children (HBC Study).

Issue Release: 2024

Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder.

Issue Release: 2024

Spontaneous Generation of Unconventional Language and Its Link with Grammatical Performance in Chinese Adults With and Without ASD.

Issue Release: 2024

Early gesture development as a predictor of autism spectrum disorder in elevated-likelihood infants of ASD.

Issue Release: 2024

Developmental Profile of Children with Autism Spectrum Disorder Versus Social Communication Disorder: A Pilot Study.

Issue Release: 2024

Accuracy of the Screening Tool for Autism in Toddlers and Young Children in the primary care setting.

Issue Release: 2024

Language defi cit in boys with autism spectrum disorder in relation to maternal reproductive health, endocrine disruptors, and delivery method.

Issue Release: 2024

Reinvigorating the Promise of the National Database for Autism Research (NDAR) to Advance Autism Knowledge.

Issue Release: 2024

Classifying autism in a clinical population based on motion synchrony: a proof-of-concept study using real-life diagnostic interviews.

Issue Release: 2024

A Direct Comparison of Three Screening Methods for Autism Spectrum Disorder in a High-Likelihood Sibling Population.

Issue Release: 2024

Overnight EEG to Forecast Epilepsy Development in Children with Autism Spectrum Disorders.

Issue Release: 2024

ADOS-2 Module 4: Psychometric Properties and Diagnostic Performance at an Autism-specialized Clinic.

Issue Release: 2024

Phenotypic characteristics and rehabilitation effect of children with regressive autism spectrum disorder: a prospective cohort study.

Issue Release: 2024

Unraveling the Spectrum: A Comprehensive Review of Autism Spectrum Disorder in India.

Issue Release: 2024

Social communication and restricted, repetitive behavior as assessed with a diagnostic tool for autism (ADOS-2) in women with anorexia nervosa.

Issue Release: 2024

What is Transitional Care?

What Are Clinical Trials?

What Roles Do Pharmacists Play in Pharma?

What are the Challenges Faced by Generic Manufacturers?

How Are Participants Protected?

Why is Generic Competition Important?

What are the Key Cellular Stress Pathways?

How Does Pharma Play a Role in Chronic Conditions?

What Causes Adverse Drug Events?

What is the Future of the Pharmacy Profession?

Autism Diagnostic Observation Schedule (ados) - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics